Examkin

Question

Difficulty: Very hardInterpreting Imaging Results

During a routine neuro-oncology follow-up, a 5555-year-old man reports worsening headaches and newly onset left-sided weakness over the past 33 weeks. His medical history is significant for a right frontal glioblastoma multiforme, managed with gross total resection and concurrent chemoradiotherapy (6060 Gy total dose) completed 77 months prior. On examination, a mild left hemiparesis is newly evident. A contrast-enhanced MRI of the brain displays a 33 cm irregular, peripherally enhancing lesion containing a central necrotic core at the margins of the previous resection bed. This is surrounded by extensive T2/FLAIR hyperintensity.

The multidisciplinary tumor board debates whether these structural findings represent true tumor recurrence or pseudoprogression (radiation necrosis). To resolve this, advanced MRI techniques are employed.

Which of the following specific combinations of advanced imaging findings would most definitively establish the diagnosis of tumor recurrence rather than radiation necrosis in this patient?

  1. Increased relative cerebral blood volume (rCBV) on MR perfusion and an elevated choline-to-creatine ratio on MR spectroscopyAnswer
  2. B
    Decreased relative cerebral blood volume (rCBV) on MR perfusion and an elevated lipid-lactate peak on MR spectroscopy
  3. C
    Profound homogeneous restricted diffusion within the central core on diffusion-weighted imaging (DWI) with a corresponding low apparent diffusion coefficient (ADC)
  4. D
    A thick, smooth, completely uniform rim of contrast enhancement on T1-weighted imaging
  5. E
    Extensive vasogenic edema characterized by hyperintensity on T2-weighted and FLAIR images with significant midline shift

Answer

The correct interpretation indicating tumor recurrence is increased relative cerebral blood volume (rCBV) on MR perfusion and an elevated choline-to-creatine ratio on MR spectroscopy.
The correct answer identifies the advanced magnetic resonance (MR) imaging characteristics of tumor recurrence. Differentiating glioblastoma recurrence from radiation necrosis (which typically peaks 33 to 1212 months post-radiotherapy) is notoriously difficult using conventional structural MRI, as both can exhibit irregular contrast enhancement, central necrosis, and extensive T2/FLAIR vasogenic edema with mass effect. Advanced imaging techniques are therefore essential. MR perfusion evaluates tissue microvascularity; recurrent tumors induce neoangiogenesis, resulting in increased relative cerebral blood volume (rCBV). In contrast, radiation necrosis causes obliterative endarteritis and tissue ischemia, leading to decreased rCBV. Furthermore, MR spectroscopy analyzes the biochemical milieu of the tissue. Actively proliferating tumor cells demonstrate increased cell membrane turnover, reflected by an elevated Choline (Cho) peak and a high Cho-to-Creatine ratio. Normal neuronal markers (like N-acetylaspartate, NAA) will be correspondingly decreased. Therefore, high rCBV and a high Cho/Cr ratio definitively support tumor recurrence.

Step-by-Step Solution

1
Analyze the clinical scenario and conventional MRI findings.
The patient presents with new neurological symptoms 77 months after completion of radiotherapy for glioblastoma. Structural MRI shows a new enhancing lesion with central necrosis and surrounding edema.
This timeline and presentation are classic for both true tumor recurrence and radiation necrosis (pseudoprogression), which often appear identical on conventional MRI.
2
Evaluate the role of advanced imaging modalities in distinguishing the two entities.
MR perfusion (measuring rCBV) and MR spectroscopy (measuring tissue metabolites) are required for definitive interpretation.
Structural findings like enhancement patterns and vasogenic edema are non-specific indicators of blood-brain barrier breakdown present in both conditions.
3
Identify the physiologic and biochemical signatures of tumor recurrence versus radiation necrosis.
Tumor recurrence is characterized by neoangiogenesis (increased rCBV) and high cellular membrane turnover (elevated Choline).
In contrast, radiation necrosis involves obliterative endarteritis (decreased rCBV) and sterile cell death resulting in cellular debris (elevated lipid/lactate peak, decreased normal metabolites).

Key Concept

Differentiating glioblastoma recurrence from radiation necrosis relies on advanced imaging: tumor recurrence shows increased perfusion (rCBV) and elevated Choline, while radiation necrosis shows decreased perfusion and elevated lipid/lactate.
Estimated Time:1m 30s
Rate this question

Topics

Interpreting Imaging Results

More questions from this topic